Colon-specific 9-aminocamptothecin-HPMA copolymer conjugates containing a 1,6-elimination spacer
- PMID: 16290118
- DOI: 10.1016/j.jconrel.2005.10.004
Colon-specific 9-aminocamptothecin-HPMA copolymer conjugates containing a 1,6-elimination spacer
Abstract
N-(2-Hydroxypropyl)methacrylamide (HPMA) copolymer-9-aminocamptothecin (9-AC) conjugate for oral colon-specific drug delivery was designed, synthesized, and characterized. The drug, 9-AC, was attached to the polymer carrier via a spacer containing a combination of an aromatic azo bond and a 4-aminobenzylcarbamate group. The design of the spacer ensured a fast and highly efficient release of unmodified 9-AC from the polymer in the colon by azo bond cleavage followed by a 1,6-elimination mechanism. An in vitro degradation study indicated that this conjugate was stable in simulated upper GI tract conditions, including small intestine (SI) contents, SI mucosa suspension, and in PBS (pH 1.5 and 7.4). A fast release of the unmodified drug (85+/-10% of 9-AC in 12 h) was detected in rat cecal contents. This drug delivery system has potential in the treatment of colon cancer.
Similar articles
-
Pharmacokinetic modeling of absorption behavior of 9-aminocamptothecin (9-AC) released from colon-specific HPMA copolymer-9-AC conjugate in rats.Pharm Res. 2008 Jan;25(1):218-26. doi: 10.1007/s11095-007-9465-3. Epub 2007 Oct 11. Pharm Res. 2008. PMID: 17929146 Free PMC article.
-
Biorecognizable HPMA copolymer-drug conjugates for colon-specific delivery of 9-aminocamptothecin.J Control Release. 2001 Aug 10;75(3):365-79. doi: 10.1016/s0168-3659(01)00405-9. J Control Release. 2001. PMID: 11489323
-
Biodistribution and pharmacokinetics of colon-specific HPMA copolymer--9-aminocamptothecin conjugate in mice.J Control Release. 2007 Feb 12;117(2):179-85. doi: 10.1016/j.jconrel.2006.10.024. Epub 2006 Oct 27. J Control Release. 2007. PMID: 17150276 Free PMC article.
-
HPMA Copolymer-Drug Conjugates with Controlled Tumor-Specific Drug Release.Macromol Biosci. 2018 Jan;18(1). doi: 10.1002/mabi.201700209. Epub 2017 Aug 14. Macromol Biosci. 2018. PMID: 28805040 Review.
-
Designing polymer conjugates as lysosomotropic nanomedicines.Biochem Soc Trans. 2007 Feb;35(Pt 1):56-60. doi: 10.1042/BST0350056. Biochem Soc Trans. 2007. PMID: 17233601 Review.
Cited by
-
Pharmacokinetic modeling of absorption behavior of 9-aminocamptothecin (9-AC) released from colon-specific HPMA copolymer-9-AC conjugate in rats.Pharm Res. 2008 Jan;25(1):218-26. doi: 10.1007/s11095-007-9465-3. Epub 2007 Oct 11. Pharm Res. 2008. PMID: 17929146 Free PMC article.
-
Polymer nanomedicines.Adv Drug Deliv Rev. 2020;156:40-64. doi: 10.1016/j.addr.2020.07.020. Epub 2020 Jul 28. Adv Drug Deliv Rev. 2020. PMID: 32735811 Free PMC article. Review.
-
Antitumor efficacy of colon-specific HPMA copolymer/9-aminocamptothecin conjugates in mice bearing human-colon carcinoma xenografts.Macromol Biosci. 2009 Nov 10;9(11):1135-42. doi: 10.1002/mabi.200900147. Macromol Biosci. 2009. PMID: 19685500 Free PMC article.
-
Targeting polymer therapeutics to bone.Adv Drug Deliv Rev. 2012 Sep;64(12):1189-204. doi: 10.1016/j.addr.2012.01.012. Epub 2012 Jan 28. Adv Drug Deliv Rev. 2012. PMID: 22316530 Free PMC article. Review.
-
POLYMERIC BIOMATERIALS AND NANOMEDICINES.J Drug Deliv Sci Technol. 2015 Dec 1;30(Pt B):318-330. doi: 10.1016/j.jddst.2015.05.012. J Drug Deliv Sci Technol. 2015. PMID: 26688694 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
